Researcher Database

Ohyama Yoshiaki
Advanced Medical Development Center
Professor
Last Updated :2025/03/27

Researcher Profile and Settings

Researcher

  • Name

    Ohyama Yoshiaki

Affiliation

  • Advanced Medical Development Center, Professor

Profile and Settings

  • Name

    Yoshiaki, Ohyama
  • Foreign name

    退職

Affiliation

  • Affiliation

    University Hospital

Research Activities

Published Papers

  • Acute myocarditis associated with COVID-19 vaccination: A case report, Nagasaka T, Koitabashi N, Ishibashi Y, Aihara K, Takama N, Ohyama Y, Yokoyama T, Kaneko Y, 2021
  • Pulmonary Artery diameter (PAD) and the pulmonary artery to aorta ratio (PAD/AAD) as assessed by non-contrast cardiac CT: the association with left ventricular (LV) remodeling and the LV function, Nguyen H, Ohyama Y, Taketomi-Takahashi A, Nguyen T, Sugimoto A, Sato M, Sumiyoshi H, Nakamura T, Kurabayashi M, Tsushima Y., 2021, Intern Med
  • Association of coronary artery calcification and thoracic aortic calcification with incident peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA), Bakhshi H, Bagchi P, Meyghani Z, Tehrani B, Quan X, Garg P, Ambale-Venkatesh B, Bhatia H, Ohyama Y, Wu C, Budoff M, Alison M, Criqui M, Bluemke D, Lima J, deFilippi C, 2021, Eur Heart J Open, 1, 3
  • Adaptive Servo-ventilation Therapy Results in the Prevention of Arrhythmias in Patients with Heart Failure due to ischemic Heart Disease, Nagasaka T, Takama N, Ohyama Y, Koitabashi N, Tange S, Kurabayashi M, 2021, Intern Med, 60, 22, 3351, 3558, Scientific journal
  • 右冠動脈入口部から末梢にかけてのびまん性冠攣縮による完全閉塞により急性心筋梗塞を発症した症例(第196回日本循環器学会関東甲信越地方会), ;;;;;;;;;;;;, Oct. 2005, Circulation journal : official journal of the Japanese Circulation Society, 69, 0, 922
  • Notch Signaling Pathway Enhances Bone Morphogenetic Protein 2 (BMP2) Responsiveness of Msx2 Gene to Induce Osteogenic Differentiation and Mineralization of Vascular Smooth Muscle Cells, Shimizu, Takehisa;Tanaka, Toru;Iso, Tatsuya;Matsui, Hiroki;Ooyama, Yoshiaki;Kawai-Kowase, Keiko;Arai, Masashi;Kurabayashi, Masahiko, 2011, JOURNAL OF BIOLOGICAL CHEMISTRY, 286, 21, 19138, 19148
  • SVGからの retrograde approach でPCIに成功したCTOの一例(第195回日本循環器学会関東甲信越地方会), ;;;;;;;;;;;, Oct. 2005, Circulation journal : official journal of the Japanese Circulation Society, 69, 0, 888
  • 50)Candidaによる感染性心内膜炎(IE)を発症し,内科的・外科的治療により根治し得た心室中隔欠損症(VSD)の一例(第198回日本循環器学会関東甲信越地方会), ;;;;;;;;;;;;, Apr. 2006, Circulation journal : official journal of the Japanese Circulation Society, 70, 0, 1100
  • Completion Report of the Overseas Training Program Awarded by Japanese Society of Clinical Pharmacology and Therapeutics in 2012, OHYAMA Yoshiaki, 2016, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 47, 2, 85, 87
  • メガホスピタル「前橋・高崎・渋川・深谷コア5治験・臨床研究病院」における特定臨床研究の実施-コロナ禍における臨床研究ネットワークの効率的な運用-, Ohyama Yoshiaki;Sumiyoshi Hisako;Masui Kazumi;Saito Etsuko;Kubota Yuka;Suga Hiroyuki;Kin Yoshitora;Kobayashi Atsushi;Sawamura Mamoru;Kakizaki Satoru;Oue Miho;Nakamura Tetsuya, 2021, Annual Scientific Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics, 42, 0, 1-P-E-6
  • 一般住民におけるヘモグロビン値と血圧の関係, ;;;;;;, Sep. 2016, 39回, 432
  • 日本人正常血圧集団における尿酸値と高血圧新規発症の関連, ;;;;;;, Sep. 2016, 39回, 433
  • 静脈血栓塞栓症の抗凝固療法による血栓退縮効果の検討, ;;;;;;;;, Sep. 2016, 64回, P
  • CIRUGUSシステムを利用した治験電磁化の運用状況の検討, ;;;;;;;;;;;, Oct. 2016, 47, Suppl., S239
  • 【高血圧 高血圧学アップデート】最新の実地診療のポイントの整理と活用 高血圧患者のリスク評価 血管病変の評価方法, 大山 善昭, Aug. 2017, 34, 8, 1283
  • 日本人一般集団におけるhemoglobin値と新規発症高血圧の性別特異的関連性(The Sex-Specific Association of Hemoglobin Level with Incident Hypertension in the Japanese General Population), ;;;;;;, Mar. 2017, 81回, PJ
  • 悪性腫瘍に合併した静脈血栓塞栓症に対するDOACを用いた「術前」血栓退縮療法, ;;;;;;;, Sep. 2017, 65回, P
  • 臨床研究に必要な知識、支援体制について 大規模多施設コホート研究Multi-Ethnic Study of Atherosclerosis(MESA)に携わった研究者としての実体験, 大山 善昭, Nov. 2017, 48, Suppl., S185
  • メガホスピタル「前橋・高崎・渋川・深谷コア5治験・臨床研究病院」における治験契約窓口の一本化の検討, ;;;;;;;;;;;, Nov. 2017, 48, Suppl., S343
  • 高血圧患者におけるCardio-Ankle Vascular Indexで評価した動脈スティッフネスと左室リモデリングおよび機能の関係, ;;;;;;;, Oct. 2017, 40回, 433
  • 一般住民における尿酸値とメタボリックシンドローム新規発症の関連, ;;;;;, Oct. 2017, 40回, 439
  • 日本人の一般集団においてヘモグロビンと新規高血圧発症の関係には男女差が存在する, ;;;;;;, Oct. 2017, 40回, 442
  • 腹囲身長比は日本人一般住民において新規高血圧発症と関連する, ;;;;;, May 2018, 7回, 205
  • CTで測定した肺動脈径と心血管病罹患率との関連, ;;;;;;;;, Sep. 2018, 41回, PC07
  • 治験におけるリモートSDVシステムの開発, ;;;;;;;;;;;, Oct. 2020, 51, Suppl., S332
  • サルコイドーシス患者におけるnative T1値による局所的な心筋瘢痕の評価 ガドリニウム遅延造影像との比較(Assessment of Focal Myocardial Scar by Native T1 Value in Sarcoidosis Patients: Comparison with Late Gadolinium Enhancement Cardiac Imaging), ;;;;, Jul. 2020, 84回, PJ17
  • DPC由来ビッグデータを用いた循環器疾患入院医療における医師誘発需要の検討 医師数、医療費、患者転帰の関連, 大山 善昭, 2020, 2020年度, 1
  • 一般住民におけるトリグリセリド/グルコース指数と動脈スティッフネスの関連(Association of Triglyceride and Glucose Index with Arterial Stiffness in the Japanese General Population), ;;;;, Oct. 2021, 43回, 334
  • 日本における循環器急性期入院治療にphysician-induced demandは存在するか? JROADデータベースによる3546181例の入院患者の分析(Does Physician-induced Demand Exist in Acute Cardiovascular Inpatient Care in Japan? An Analysis of 3,546,181 Admissions from JROAD Database), ;;;;;;, Mar. 2022, 86回, PJ35
  • メガホスピタル「前橋・高崎・渋川・深谷コア5治験・臨床研究病院」における特定臨床研究の実施 コロナ禍における臨床研究ネットワークの効率的な運用, ;;;;;;;;;;;, Dec. 2021, 42回, 1
  • 局所進行子宮頸部腺癌に対する重粒子線治療の多施設前向き登録研究, ;;;;;;;;;;;;, Oct. 2022, 60回, YOA O62
  • 臨床研究のデータ入力とモニタリング省力化の取り組み 電子カルテネットワーク内のHOPE eACReSS設置, ;;;;;;;;;;;, Dec. 2022, 43回, 4
  • 中心性漿液性脈絡網膜症における渦静脈うっ滞の改善を目的とした1象限レーザー光凝固, ;;;;;;;;;, Mar. 2023, 127, 臨増, 238
  • Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells., Shimizu Takehisa;Tanaka Toru;Iso Tatsuya;Matsui Hiroki;Ooyama Yoshiaki;Kawai-Kowase Keiko;Arai Masashi;Kurabayashi Masahiko, Apr. 2011, The Journal of biological chemistry, 286, 21
  • メガホスピタル「前橋・高崎・渋川・深谷コア5治験・臨床研究病院」における特定臨床研究の実施 コロナ禍における臨床研究ネットワークの効率的な運用, ;;;;;;;;;;;, Dec. 2021, 42回, 1
  • 4. 循環器領域でClopidogrelに期待されること(第3回群馬血栓症研究会), ;;;;;;;;;;;;;, Aug. 2005, 55, 3, 298, 298
  • 透析患者の心血管合併症, ;, Jan. 2012, 2, 1, 40, 46
  • アンチエイジングから弁膜症を考える, ;, Jul. 2012, 4, 2, 94, 98
  • 安定労作性狭心症, ;, Jan. 2013, 101, 1, 65, 70
  • Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription., Watanabe Atai;Arai Masashi;Koitabashi Norimichi;Niwano Kazuo;Ohyama Yoshiaki;Yamada Yoshihumi;Kato Noriko;Kurabayashi Masahiko, Nov. 2010, Cardiovascular research, 90, 1
  • Serum syndecan-4 is a novel biomarker for patients with chronic heart failure., Takahashi Rieko;Negishi Kazuaki;Watanabe Atai;Arai Masashi;Naganuma Fumio;Ohyama Yoshiaki;Kurabayashi Masahiko, Mar. 2011, Journal of cardiology, 57, 3
  • Demonstration of a sex difference in the predictability of widths of unerupted permanent canines and premolars in a Japanese population., Tome Wakako;Ohyama Yoshiaki;Yagi Masakazu;Takada Kenji, Jul. 2011, The Angle orthodontist, 81, 6
  • Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular smooth muscle cells., Ohyama Yoshiaki;Tanaka Toru;Shimizu Takehisa;Matsui Hiroki;Sato Hiroko;Koitabashi Norimichi;Doi Hiroshi;Iso Tatsuya;Arai Masashi;Kurabayashi Masahiko, Oct. 2011, Journal of atherosclerosis and thrombosis, 19, 1
  • Estimated glomerular filtration rate and proteinuria are separately and independently associated with the prevalence of atrial fibrillation in general population., Ohyama Yoshiaki;Imai Masahiko;Kurabayashi Masahiko, Nov. 2013, PloS one, 8, 11
  • Subclinical Myocardial Disease in Heart Failure Detected by CMR., Ohyama Yoshiaki;Volpe Gustavo J;Lima Joao A C, Current cardiovascular imaging reports, 7
  • Proximal aortic distensibility is an independent predictor of all-cause mortality and incident CV events: the MESA study., Redheuil Alban;Wu Colin O;Kachenoura Nadjia;Ohyama Yoshiaki;Yan Raymond T;Bertoni Alain G;Hundley Gregory W;Duprez Daniel A;Jacobs David R;Daniels Lori B;Darwin Christine;Sibley Christopher;Bluemke David A;Lima João A C, Journal of the American College of Cardiology, 64, 24
  • Comparison of strain measurement from multimodality tissue tracking with strain-encoding MRI and harmonic phase MRI in pulmonary hypertension., Ohyama Yoshiaki;Ambale-Venkatesh Bharath;Chamera Elzbieta;Shehata Monda L;Corona-Villalobos Celia P;Zimmerman Stefan L;Hassoun Paul M;Bluemke David A;Lima Joao A C, Jan. 2015, International journal of cardiology, 182
  • Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment., Koitabashi Norimichi;Niwamae Nogiku;Taguchi Tetsuya;Ohyama Yoshiaki;Takama Noriaki;Kurabayashi Masahiko, Mar. 2015, Thrombosis journal, 13
  • Reversible Cardiomyopathy After Epirubicin Administration., Koitabashi Norimichi;Ohyama Yoshiaki;Tateno Rieko;Arai Masashi;Rokutanda Nana;Horiguchi Jun;Kurabayashi Masahiko, Jun. 2015, International heart journal, 56, 4
  • A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts., Obokata Masaru;Negishi Kazuaki;Ohyama Yoshiaki;Okada Haruka;Imai Kunihiko;Kurabayashi Masahiko, Jul. 2015, PloS one, 10, 7
  • Reproducibility of functional aortic analysis using magnetic resonance imaging: the MESA., Noda Chikara;Ambale Venkatesh Bharath;Ohyama Yoshiaki;Liu Chia-Ying;Chamera Elzbieta;Redheuil Alban;Teixido-Tura Gisela;Chugh Atul R;Wu Colin O;Hundley Gregory W;Bluemke David A;Lima Joao A C, Sep. 2015, European heart journal. Cardiovascular Imaging, 17, 8
  • Ten-year longitudinal change in aortic stiffness assessed by cardiac MRI in the second half of the human lifespan: the multi-ethnic study of atherosclerosis., Ohyama Yoshiaki;Teixido-Tura Gisela;Ambale-Venkatesh Bharath;Noda Chikara;Chugh Atul R;Liu Chia-Ying;Redheuil Alban;Stacey R Brandon;Dietz Harry;Gomes Antoinette S;Prince Martin R;Evangelista Arturo;Wu Colin O;Hundley W Gregory;Bluemke David A;Lima Joao A C, Jan. 2016, European heart journal. Cardiovascular Imaging, 17, 9
  • Association of Aortic Stiffness With Left Ventricular Remodeling and Reduced Left Ventricular Function Measured by Magnetic Resonance Imaging: The Multi-Ethnic Study of Atherosclerosis., Ohyama Yoshiaki;Ambale-Venkatesh Bharath;Noda Chikara;Chugh Atul R;Teixido-Tura Gisela;Kim Jang-Young;Donekal Sirisha;Yoneyama Kihei;Gjesdal Ola;Redheuil Alban;Liu Chia-Ying;Nakamura Tetsuya;Wu Colin O;Hundley W Gregory;Bluemke David A;Lima Joao A C, Circulation. Cardiovascular imaging, 9, 7
  • Left ventricular shape predicts different types of cardiovascular events in the general population., Ambale-Venkatesh Bharath;Yoneyama Kihei;Sharma Ravi K;Ohyama Yoshiaki;Wu Colin O;Burke Gregory L;Shea Steven;Gomes Antoinette S;Young Alistair A;Bluemke David A;Lima João Ac, Sep. 2016, Heart (British Cardiac Society), 103, 7
  • Electrocardiographic Impact of Myocardial Diffuse Fibrosis and Scar: MESA (Multi-Ethnic Study of Atherosclerosis)., Inoue Yuko Y;Ambale-Venkatesh Bharath;Mewton Nathan;Volpe Gustavo J;Ohyama Yoshiaki;Sharma Ravi K;Wu Colin O;Liu Chia-Ying;Bluemke David A;Soliman Elsayed Z;Lima João A C;Ashikaga Hiroshi, Oct. 2016, Radiology, 282, 3
  • Aortic Arch Pulse Wave Velocity Assessed by Magnetic Resonance Imaging as a Predictor of Incident Cardiovascular Events: The MESA (Multi-Ethnic Study of Atherosclerosis)., Ohyama Yoshiaki;Ambale-Venkatesh Bharath;Noda Chikara;Kim Jang-Young;Tanami Yutaka;Teixido-Tura Gisela;Chugh Atul R;Redheuil Alban;Liu Chia-Ying;Wu Colin O;Hundley W Gregory;Bluemke David A;Guallar Eliseo;Lima Joao A C, Jul. 2017, Hypertension (Dallas, Tex. : 1979), 70, 3
  • Association of Aortic Root Dilation from Early Adulthood to Middle Age with Cardiac Structure and Function: The CARDIA Study., Nwabuo Chike C;Moreira Henrique T;Vasconcellos Henrique D;Ambale-Venkatesh Bharath;Yoneyama Kihei;Ohyama Yoshiaki;Sharma Ravi K;Armstrong Anderson C;Ostovaneh Mohammed R;Lewis Cora E;Liu Kiang;Schreiner Pamela J;Ogunyankin Kofo O;Gidding Samuel S;Lima João A C, Sep. 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 30, 12
  • Relation of Sex Hormone Levels With Prevalent and 10-Year Change in Aortic Distensibility Assessed by MRI: The Multi-Ethnic Study of Atherosclerosis., Subramanya Vinita;Ambale-Venkatesh Bharath;Ohyama Yoshiaki;Zhao Di;Nwabuo Chike C;Post Wendy S;Guallar Eliseo;Ouyang Pamela;Shah Sanjiv J;Allison Matthew A;Ndumele Chiadi E;Vaidya Dhananjay;Bluemke David A;Lima Joao A;Michos Erin D, American journal of hypertension, 31, 7
  • Imaging Insights on the Aorta in Aging., Ohyama Yoshiaki;Redheuil Alban;Kachenoura Nadjia;Ambale Venkatesh Bharath;Lima Joao A C, Circulation. Cardiovascular imaging, 11, 4
  • Association of Aortic Arch Width Assessed by Noncontrast Cardiac Computed Tomography With Cardiac Remodeling, Cardiac Function, and Atherosclerosis in a Japanese Cohort., Nguyen-Thu Huong;Ohyama Yoshiaki;Taketomi-Takahashi Ayako;Nguyen-Cong Tien;Sugimoto Akio;Sato Makito;Sumiyoshi Hisako;Nakamura Tetsuya;Kurabayashi Masahiko;Tsushima Yoshito, Journal of thoracic imaging, 33, 4
  • Early increase in serum fatty acid binding protein 4 levels in patients with acute myocardial infarction., Obokata Masaru;Iso Tatsuya;Ohyama Yoshiaki;Sunaga Hiroaki;Kawaguchi Tomoka;Matsui Hiroki;Iizuka Takashi;Fukuda Nobuaki;Takamatsu Hiroto;Koitabashi Norimichi;Funada Ryuichi;Takama Noriaki;Kasama Shu;Kaneko Yoshiaki;Yokoyama Tomoyuki;Murakami Masami;Kurabayashi Masahiko, Dec. 2016, European heart journal. Acute cardiovascular care, 7, 6
  • Influence of cardiac function on image quality in coronary computed tomography angiography., Nguyen Tien C;Ohyama Yoshiaki;Taketomi-Takahashi Ayako;Nguyen Huong T;Sugimoto Akio;Sato Makito;Sumiyoshi Hisako;Nakamura Tetsuya;Kurabayashi Masahiko;Tsushima Yoshito, Oct. 2018, Clinical imaging, 53
  • Association of myocardial fibrosis and cardiovascular events: the multi-ethnic study of atherosclerosis., Ambale-Venkatesh Bharath;Liu Chia-Ying;Liu Yuan-Chang;Donekal Sirisha;Ohyama Yoshiaki;Sharma Ravi K;Wu Colin O;Post Wendy S;Hundley Gregory W;Bluemke David A;Lima João A C, European heart journal. Cardiovascular Imaging, 20, 2
  • Multiple spontaneous coronary artery ruptures and cardiac tamponade in vascular Ehlers-Danlos syndrome., Ohyama Yoshiaki;Iso Tatsuya;Niño Adriana Carolina Vargas;Obokata Masaru;Takahashi Rieko;Okumura Wataru;Nakano Akihiko;Amano Masao;Naito Isao;Takatama Masamitsu;Kurabayashi Masahiko, Nov. 2010, Journal of cardiology cases, 3, 1
  • Pulmonary hypertension with extensive calcification in small pulmonary vessels and alveolar capillary wall in a chronic hemodialysis patient., Ohyama Yoshiaki;Tsuchiya Hiroko;Kurosawa Koji;Nakano Akihiko;Arai Masashi;Nobusawa Sumihito;Nakazato Yoichi;Kurabayashi Masahiko, Apr. 2013, Journal of cardiology cases, 8, 1
  • Association of Uric Acid with Incident Metabolic Syndrome in a Japanese General Population., Sumiyoshi Hisako;Ohyama Yoshiaki;Imai Kunihiko;Kurabayashi Masahiko;Saito Yuichiro;Nakamura Tetsuya, Jun. 2019, International heart journal, 60, 4
  • Impact of uric acid on incident hypertension: Sex-specific analysis in different age groups., Ohyama Yoshiaki;Imai Kunihiko;Obokata Masaru;Araki Mie;Sumiyoshi Hisako;Koitabashi Norimichi;Nakamura Tetsuya;Kurabayashi Masahiko, May 2019, International Journal of Cardiology. Hypertension, 2
  • Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan - JROAD and JROAD-DPC Registry Analysis., Ohyama Yoshiaki;Koitabashi Norimichi;Nakamura Tetsuya;Sumita Yoko;Nakai Michikazu;Nishimura Kunihiro;Miyamoto Yoshihiro;Kurabayashi Masahiko, Jun. 2019, Circulation reports, 1, 7
  • Adaptive Servo-ventilation Therapy Results in the Prevention of Arrhythmias in Patients with Heart Failure Due to Ischemic Heart Disease., Nagasaka Takashi;Takama Noriaki;Ohyama Yoshiaki;Koitabashi Norimichi;Tange Shoichi;Kurabayashi Masahiko, Jun. 2021, Internal medicine (Tokyo, Japan), 60, 22
  • Pulmonary Artery Diameter (PAD) and the Pulmonary Artery to Aorta Ratio (PAD/AAD) as Assessed by Non-contrast Cardiac CT: The Association with Left Ventricular (LV) Remodeling and the LV Function., Nguyen-Thu Huong;Ohyama Yoshiaki;Taketomi-Takahashi Ayako;Nguyen-Cong Tien;Sumiyoshi Hisako;Nakamura Tetsuya;Kurabayashi Masahiko;Tsushima Yoshito, Nov. 2021, Internal medicine (Tokyo, Japan), 61, 12
  • Acute myocarditis associated with COVID-19 vaccination: A case report., Nagasaka Takashi;Koitabashi Norimichi;Ishibashi Yohei;Aihara Kazufumi;Takama Noriaki;Ohyama Yoshiaki;Yokoyama Tomoyuki;Kaneko Yoshiaki, Dec. 2021, Journal of cardiology cases, 25, 5
  • Association of coronary artery calcification and thoracic aortic calcification with incident peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA)., Bakhshi Hooman;Bagchi Pramita;Meyghani Zahra;Tehrani Behnam;Qian Xiaoxiao;Garg Parveen K;Ambale-Venkatesh Bharath;Bhatia Harpreet S;Ohyama Yoshiaki;Wu Colin O;Budoff Matthew;Allison Matthew;Criqui Michael H;Bluemke David A;Lima Joao A C;deFilippi Christopher R, Dec. 2021, European heart journal open, 1, 3
  • Impact of left atrial enlargement on image quality in coronary computed tomography angiography., Nguyen Tien C;Ohyama Yoshiaki;Taketomi-Takahashi Ayako;Nguyen Huong T;Sumiyoshi Hisako;Nakamura Tetsuya;Kurabayashi Masahiko;Tsushima Yoshito, Jan. 2022, Clinical imaging, 84
  • The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study., Yanagisawa Kunio;Takara Katsuhiko;Suga Hiroyuki;Saito Akio;Hayashi Toshimasa;Igarashi Tsuneo;Tomizawa Sachi;Saito Etsuko;Sumiyoshi Hisako;Ohyama Yoshiaki;Tokue Yutaka;Nakamura Tetsuya, Aug. 2022, Internal medicine (Tokyo, Japan), 61, 21
  • Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve., Nagasaka Takashi;Amanai Shiro;Ishibashi Yohei;Aihara Kazufumi;Ohyama Yoshiaki;Takama Noriaki;Koitabashi Norimichi;Ishii Hideki, Oct. 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 100, 6
  • Quadrant laser photocoagulation trial to ameliorate choroidal congestion in central serous chorioretinopathy., Matsumoto Hidetaka;Hoshino Junki;Nakamura Kosuke;Ohyama Yoshiaki;Morimoto Masahiro;Mukai Ryo;Sumiyoshi Hisako;Nakamura Tetsuya;Kishi Shoji;Akiyama Hideo, Feb. 2023, Japanese journal of ophthalmology, 67, 2
  • Drug-coated balloons for the treatment of stent edge restenosis., Nagasaka Takashi;Amanai Shiro;Ishibashi Yohei;Aihara Kazufumi;Ohyama Yoshiaki;Takama Noriaki;Koitabashi Norimichi;Ishii Hideki, Mar. 2023, Coronary artery disease, 34, 4
  • CTで評価したaortic unfoldingと、心臓リモデリングおよび心機能との相関(Association of aortic unfolding assessed by computed tomography(CT) with cardiac remodeling and function), ;;;;;;;;;, Sep. 2017, 64, 9, 1262
  • 冠動脈コンピュータ断層血管造影(CCTA)の画質に及ぼす肺血流の影響(Effect of the Pulmonary Circulation on the Quality Image in Coronary Computed Tomography Angiography(CCTA)), ;;;;;;;;, Feb. 2018, 77回, S246
  • 心室誘導/エントレインメント直後にV-A-A-V反応を適用することにより非定型房室結節性リエントリー性頻拍と心房性頻拍を鑑別する(Discrimination of Atypical Atrioventricular Nodal Reentrant Tachycardia from Atrial Tachycardia by Applying V-A-A-V Response Immediately after Ventricular Induction/Entrainment), ;;;;;;;, Mar. 2018, 82回, OE40
  • 日本人一般集団におけるuric acidの偶発的メタボリックシンドロームとの関連性(Association of Uric Acid with Incident Metabolic Syndrome in the Japanese General Population), ;;;;;, Mar. 2017, 81回, PE
  • 急性心血管イベント発現後の血清FABP4レベルは遊離脂肪酸よりも大きく変化する(A Preferential Change in Serum FABP4 Levels Compared with Free Fatty Acid after Onset of Acute Cardiovascular Events), ;;;;;;;;;;;;;;, Mar. 2016, 80, Suppl.I, 2932
  • 日本人一般集団におけるuric acidの高血圧発症との関連性(Association of Uric Acid with Incident Hypertension in the Japanese General Population), ;;;;, Mar. 2016, 80, Suppl.I, 2034
  • 心不全患者における循環中FABP4と心拍との関連性(Relationship between Circulating FABP4 and Heart Rate in the Patients with Heart Failure), ;;;;;;;;;;;;, Mar. 2015, 79, Suppl.I, 1991
  • 近位深部静脈血栓症の早期退縮に関してvitamin K拮抗薬と比較した直接経口抗凝固薬の有効性(Effectiveness of Direct Oral Anticoagulants for Early Regression of Proximal Deep Vein Thrombosis Compared with Vitamin K Antagonists), ;;;;;;;;;;;;, Mar. 2017, 81回, PE
  • 冠動脈CT血管造影(CCTA)の画像品質に対する血行動態パラメータの影響(Influence of hemodynamic parameters on image quality in coronary computed tomography angiography(CCTA)), ;;;;;;;;;, Sep. 2017, 64, 9, 1261
  • 日本人一般集団における高血圧発症の予測に対する腹囲/身長比(Waist to Height Ratio for Predicting Incident Hypertension in the Japanese General Population), ;;;;;, Mar. 2018, 82回, PE112
  • 日本人集団における再発性静脈血栓塞栓症に対する下大静脈フィルターの効果(Effect of Inferior Vena Cava Filter on Recurrent Venous Thromboembolism in the Japanese Population), ;;;;;;;;, Mar. 2018, 82回, PE123
  • 日本人一般集団における尿酸値とメタボリックシンドローム発生率との関連性(Association of Uric Acid with Incident Metabolic Syndrome in a Japanese General Population), ;;;;;, Jul. 2019, 60, 4, 830
  • 日本における静脈血栓塞栓症死亡率に対する下大静脈フィルターの影響 JROADおよびJROAD-DPCレジストリ解析(Effect of Inferior Vena Cava Filter on Venous Thromboembolism Mortality in Japan: JROAD and JROAD-DPC Registry Analysis), ;;;;;;;, Jul. 2019, 1, 7, 296
  • 日本人一般集団における動脈壁硬化とフレイルの関連(Cross-Sectional Association of Arterial Stiffness with Frailty in the Japanese General Population), ;;;;;;;;;, Mar. 2021, 85回, OE126
  • 日本人一般集団におけるTyG indexと高血圧発症との関連(Association of Triglyceride and Glucose Index with Incident Hypertension in the Japanese General Population), ;;;;;, Mar. 2021, 85回, OE127
  • 健診受診者におけるフレイルと栄養関連因子の関係, ;;;;;;;;;;;;, Oct. 2021, 3, Suppl.1, 676
  • 虚血性心疾患による心不全患者の不整脈予防におけるアダプティブサーボ・ベンチレーション療法の結果(Adaptive Servo-ventilation Therapy Results in the Prevention of Arrhythmias in Patients with Heart Failure Due to Ischemic Heart Disease), ;;;;;, Nov. 2021, 60, 22, 3551
  • 前壁ST上昇型心筋梗塞後のGrayzoneの経時的変化とLGEとの相関 LAST-PASS MRIサブスタディ, ;;;;;;;;, Jul. 2022, 30回, [MP006]
  • 難治性婦人科がんの克服を目指して 子宮頸部腺癌に対する重粒子線治療の全国前向き登録レジストリ解析報告, ;;;;;;;;;;;;, Jul. 2022, 64回, 100
  • COVID-19ワクチンによる急性心筋炎 1症例報告(Acute myocarditis associated with COVID-19 vaccination: A case report), ;;;;;;;, May 2022, 25, 5, 285
  • 非造影心臓CTで評価した肺動脈径(PAD)および肺動脈径/大動脈径比(PAD/AAD) 左室リモデリングおよび左室機能との関連性(Pulmonary Artery Diameter(PAD) and the Pulmonary Artery to Aorta Ratio(PAD/AAD) as Assessed by Non-contrast Cardiac CT: The Association with Left Ventricular(LV) Remodeling and the LV Function), ;;;;;;;, Jun. 2022, 61, 12, 1809
  • SARS-CoV-2感染患者に対するファビピラビルの有効性および安全性の評価 多施設共同非ランダム化非対照単群前向き試験(The Assessment of the Efficacy and Safety of Favipiravir for Patients with SARS-CoV-2 Infection: A Multicenter Non-randomized, Uncontrolled Single-arm Prospective Study), ;;;;;;;;;;;, Nov. 2022, 61, 21, 3197
  • 中心性漿液性脈絡網膜症における脈絡膜うっ血を改善するための四象限レーザー光凝固試験(Quadrant laser photocoagulation trial to ameliorate choroidal congestion in central serous chorioretinopathy), ;;;;;;;;;, Mar. 2023, 67, 2, 156
  • 日本における抗リン脂質抗体症候群合併静脈血栓塞栓症の管理の実際。COMMAND VTE Registry-2より(Actual Management of Venous Thromboembolism Complicated by Antiphospholipid Antibody Syndrome in Japan. From the COMMAND VTE Registry-2), ;;;;;;;;;;;;;;;;;;;, Mar. 2023, 87回, OE20
  • 院内静脈血栓塞栓症予防のための質改善プロジェクトが癌関連血栓症に及ぼす効果(Effects of the Quality Improvement Project to Prevent in-hospital Venous Thromboembolism on Cancer-Related Thrombosis), ;;;;;;, Mar. 2023, 87回, OE25
  • 経口糖負荷後の「遅発性高インスリン血症」は、インスリン抵抗性が認められない場合でも急性冠症候群と関連する("Delayed Hyperinsulinemia" after Oral Glucose Load is Associated with Acute Coronary Syndrome, even though Insulin Resistance is not Observed), ;;;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 3
  • 睡眠呼吸障害患者において推定糸球体濾過率低値は全死因死亡率の上昇と関連する(Low Estimated Glomerular Filtration Rate is Associated with Increased All-Cause Mortality in Patient with Sleep-Disordered Breathing), ;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 82
  • 心不全患者における酸素飽和度によるadaptive servo ventilation療法の効果予測(Prediction of Response to Adaptive Servo Ventilation Therapy by Oxygen Saturation Values in Heart Failure Patients), ;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 2
  • 動脈血CO2分圧の変化は、心不全患者におけるadaptive servo ventilation療法への反応と関連する(Change of Arterial CO2 Tension is Associated with the Response to Adaptive Servo Ventilation in Patient with Heart Failure), ;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 3
  • 血中fatty acid binding protein 4は急性心筋梗塞の初期指標である(Circulating Fatty Acid Binding Protein 4 is an Early Marker for Acute Myocardial Infarction), ;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 8
  • 睡眠呼吸障害患者における血清n-3/n-6 polyunsaturated fatty acidと致死性心血管イベントとの関連性(Relationship between Serum n-3/n-6 Polyunsaturated Fatty Acid and Fatal Cardiovascular Events in Patient with Sleep Disordered Breathing), ;;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 57
  • 経口ブドウ糖負荷後の「遅発性高インスリン血症」は耐糖能障害期における冠動脈疾患と関連する("Delayed Hyperinsulinemia" after Oral Glucose Load is Associated with Coronary Artery Disease in Impaired Glucose Tolerance Phase), ;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 91
  • 一般集団において推算糸球体濾過率と蛋白尿は心房細動の有病率と独立した相関を示す(Estimated Glomerular Filtration Rate and Proteinuria are Independently Associated with the Prevalence of Atrial Fibrillation in General Population), ;, Mar. 2013, 77, Suppl.I, 117
  • 急性心筋梗塞患者と急性心不全患者における脂肪酸結合蛋白のアイソフォーム値の時間依存性変化の差(Differential Time-dependent Changes in Fatty Acid Binding Protein Isoforms Levels in Patients with Acute Myocardial Infarction and Acute Heart Failure), ;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 25
  • 心不全患者においてポリソムノグラフィーはAdaptive Servo-Ventilation療法に対する重要な検査か(Is Polysomnography Essential Examination for Adaptive Servo-Ventilation Therapy in Patient with Heart Failure?), ;;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 86
  • 心不全患者においてAdaptive Servo-Ventilation療法の中止は長期致死的心血管イベントと関連する(Discontinuation of Adaptive Servo Ventilation Therapy is Associated with Long-term Fatal Cardiovascular Events in Patients with Heart Failure), ;;;;;;;;;;;;;;, Mar. 2013, 77, Suppl.I, 86
  • 脂肪酸結合タンパクFABP4は急性心筋梗塞の早期診断マーカーとして有用である, ;;;;;;;;;, Sep. 2015, 22回, 136
  • エピルビシン投与後の可逆性心筋症(Reversible Cardiomyopathy After Epirubicin Administration), ;;;;;;, Jul. 2015, 56, 4, 466
  • 血中脂肪酸結合蛋白FABP4濃度は急性心筋梗塞および心停止患者で急激に上昇する, ;;;;, Sep. 2015, 63回, 872
  • 血清尿酸濃度は中年集団ベースのコホートにおいてメタボリックシンドロームの発現と関連する(Serum Uric Acid Levels are Associated with the Development of Metabolic Syndrome in a Middle-Aged Population-Based Cohort), ;;;;, Mar. 2014, 78, Suppl.I, 326
  • 急性冠症候群患者における血清FABP3、FABP4、FABP5の特異的な放出動態(Differential Release Kinetic of Serum FABP3, FABP4 and FABP5 in the Patients with Acute Coronary Syndrome), ;;;;;;;;;;;, Mar. 2014, 78, Suppl.I, 256
  • 血中FABP4は急性心血管イベント時にβ3受容体を介した交感神経活性化により脂肪細胞と毛細血管内皮細胞から放出される(Circulating FABP4 is Released from Adipocytes and Capillary Endothelial Cells by Sympathetic Activation via β3 Receptor during Acute Cardiovascular Event), ;;;;;;;, Mar. 2014, 78, Suppl.I, 351
  • 急性心筋梗塞患者における血中fatty acid binding protein 4値の早期増加 心筋虚血の新規マーカーとしての脂肪分解(Early Increase in Circulating Fatty Acid Binding Protein 4 Levels in Patients with Acute Myocardial Infarction: Lipolysis as a novel marker for myocardial ischemia), ;;;;;;;;;;;;;, Mar. 2015, 79, Suppl.I, 626
  • 急性心筋梗塞のマーカーとしてのfatty acid-binding protein 5(Fatty Acid-Binding Protein 5 as a Marker for Acute Myocardial Infarction), ;;;;;;;;;;;;, Mar. 2015, 79, Suppl.I, 1029
  • Transient Left Ventricular Apical Ballooning(TLVAB)を呈した冠攣縮性狭心症の一例 当院における10年間のTLVAB症例の検討を含めて, ;;;;;;;;;;, Aug. 2011, 48, 8, 785
  • 【"心腎連携"が必要な病態の理解と対策】透析患者の心血管合併症, ;, Jan. 2012, 2, 1, 40
  • ローカルデータマネージャーによる製造販売後調査の支援, ;;;;;;;;;;;, Oct. 2011, 42, Suppl., S226
  • 血性腹水と心嚢液貯留および呼吸不全を呈した、瀰漫性リンパ管腫症の1例, ;;;;;;;;;, Mar. 2012, 586回, 24
  • 血管Ehlers-Danlos症候群における複数冠動脈の自然破裂と心タンポナーデ(Multiple spontaneous coronary artery ruptures and cardiac tamponade in vascular Ehlers-Danlos syndrome), ;;;;;;;;;;, Feb. 2011, 3, 1, e29
  • 【アンチエイジングから心疾患を考える】アンチエイジングから弁膜症を考える, ;, Jul. 2012, 4, 2, 94
  • 閉塞シャント不全に対するPTA後抗凝固療法の有効性と安全性, ;;;;;;;;;;;;;, May 2012, 45, Suppl.1, 418
  • 2年間に冠動脈形成術を受けた維持血液透析患者の臨床像 単一施設での検討, ;;;;;;;;;;;;;;, May 2012, 45, Suppl.1, 455
  • 僧帽弁閉鎖不全症およびネフローゼ症候群による肺水腫の治療中に器質化肺炎を合併した1例, ;;;;;;;;;, Sep. 2012, 590回, 37
  • 血性胸腹水と心嚢液貯留および呼吸不全を呈した、びまん性リンパ管腫症の一例, ;;;;;;;, Jul. 2012, 49, 7, 966
  • Adaptive servo ventilationによる心不全治療の長期予後について 2年経過報告のサブ解析, ;;;;;;;;;;;;;, Aug. 2012, 7, Suppl.I, 375
  • 【虚血性心疾患】安定労作性狭心症, ;, Jan. 2013, 101, 1, 65
  • Runx2/Smad3複合体は血管平滑筋細胞においてTGF-β誘導性の結合組織成長因子の遺伝子発現を抑制する(Runx2/Smad3 Complex Negatively Regulates TGF-β-Induced Connective Tissue Growth Factor gene Expression in Vascular Smooth Muscle Cells), ;;;;;;;;;, Jan. 2012, 19, 1, 23
  • ローカルデータマネージャーの調査票作成支援により製造販売後調査実施率は向上する, ;;;;;;;;;;, Oct. 2012, 43, Suppl., S255
  • 【脂質異常症-基礎・臨床研究の最新知見-】脂質異常症・動脈硬化症の治療 薬物治療の選択基準および使用上の留意点 その他脂質異常改善薬 ARB, ;, Jun. 2013, 71, 増刊3 脂質異常症, 585
  • 遅発性緊張病に対し電気けいれん療法を施行した重症閉塞性肥大型心筋症の1例, ;;;;;;;;;, Sep. 2013, 599回, 63
  • 治験におけるリモートSDVロボット「ちけんモニ太君」の開発, ;;;;;;;;;;;, Nov. 2013, 44, Suppl., S333
  • 慢性血液透析患者における小さな肺血管と肺胞毛細血管壁の広範囲石灰化を伴った肺高血圧症(Pulmonary hypertension with extensive calcification in small pulmonary vessels and alveolar capillary wall in a chronic hemodialysis patient), ;;;;;;;, Jul. 2013, 8, 1, e13
  • 脂肪酸結合蛋白FABP4は急性冠症候群患者における来院時高血糖と関連する, ;;;;;;;;;;, Sep. 2014, 62回, O
  • PTAおよび血管内照射が奏功しているASOの一例, ;;;;;;;;;;;;, Oct. 2005, 42, 10, 1123
  • ヒト不全心筋におけるエリスロポエチン受容体発現の誘導(Expression of Erythropoietin Receptor is Induced in Human Failing Myocardium), ;;;;;;, Mar. 2006, 70, Suppl.I, 118
  • 血管年齢のアンチエイジングを目指して 血管石灰化とプラークの破綻, ;;;;;;;, Jun. 2008, 8回, 111
  • 新規心臓特異的骨形態形成蛋白質のBMP10はSERCA2発現及びホスホランバンリン酸化を増加させる(BMP10, a novel heart-specific bone morphogenetic protein, increases SERCA2 expression and phospholamban phosphorylation), ;;;;;;;, Mar. 2008, 72, Suppl.I, 311
  • 血管平滑筋細胞における骨原性転写因子Runx2による結合組織成長因子遺伝子発現及びTGFベータシグナリングの抑制(Osteogenic Transcription Factor Runx2 represses Connective Tissue Growth Factor Gene Expression and TGFbeta Signaling in Vascular Smooth Muscle Cells), ;;;;;;;, Mar. 2008, 72, Suppl.I, 568
  • 血清シンデカン4は慢性心不全患者における心機能不全の新しいバイオマーカーである, ;;;;;;;;, Aug. 2008, 2, Suppl.I, 285
  • 動脈硬化プラーク破綻機序の解明 Runx2によるTGFβシグナルとCTGF遺伝子発現の抑制, ;;;, Apr. 2009, 9回, 232
  • ミトコンドリア転写因子Tfam及びTfb2mの新しい役割 病態心臓におけるSERCA2遺伝子の転写制御(A Novel Role of Mitochondrial Transcription Factors, Tfam and Tfb2m: Transcriptional Regulation of SERCA2 Gene in the Diseased Heart), ;;;, Mar. 2009, 73, Suppl.I, 223
  • 血管平滑筋細胞においてRunx2はTGFβ/Smad介在性結合組織成長因子の遺伝子発現を抑制する(Runx2 Represses TGFβ/Smad-mediated Connective Tissue Growth Factor Gene Expression in Vascular Smooth Muscle Cells), ;;;;;;;;;, Mar. 2009, 73, Suppl.I, 575
  • 国際共同治験のための治験専用検体処理保管室の整備, ;;;;;;;;, Nov. 2009, 40, Suppl., S165
  • Runx2は、血管平滑筋細胞においてSmad3との物理的結合を介して、TGFβ誘起性結合組織成長因子遺伝子発現を抑制する(Runx2 Inhibits TGFβ-induced Connective Tissue Growth Factor Gene Expression through Physical Association with Smad3 in Vascular Smooth Muscle Cells), ;;;;;;;;, Mar. 2010, 74, Suppl.I, 772
  • 特発性冠動脈穿孔を発症したEhlers-Danlos症候群4型の一例, ;;;;;;;;;, Aug. 2010, 5, Suppl.I, 334
  • 動脈硬化プラーク破綻機序の解明 Runx2によるTGFβシグナルとCTGF遺伝子発現の抑制, ;;;, Jul. 2009, 27回, 174
  • 治験専用検体処理保管室運用に関する報告, ;;;;;;;;;, Nov. 2010, 41, Suppl., S293
  • 血清syndecan-4は慢性心不全患者の新しい生物標識である(Serum syndecan-4 is a novel biomarker for patients with chronic heart failure), ;;;;;;, May 2011, 57, 3, 325
  • 1年間に冠動脈形成術を受けた維持透析患者の臨床像 単一施設での検討, ;;;;;;;;;;, May 2011, 44, Suppl.1, 384
  • 透析症例はこうしてPCIに至る 重症心虚血発見のきっかけ, ;;;;;;;;, May 2011, 44, Suppl.1, 385
  • 閉塞AVシャントに対するIVT(interventional therapy)の有用性, ;;;;;;;, May 2011, 44, Suppl.1, 512
  • 慢性活動性EBウイルス感染症から血球貪食症候群(EBVAHS)をきたした一例, ;;;;, Feb. 2003, 506回, 19
  • 術後急速に進行した低分化肝細胞癌の1例, ;;;;;;;, Feb. 2004, 65, 2, 575
  • CTOに対するDCA+POBA施行後の多発性冠動脈瘤に対してAutologous Vein Coated STENTを植え込んだOMIの1例, ;;;;;;;;;;;, Apr. 2005, 69, Suppl.II, 839
  • 切迫破裂を来した炎症性胸部大動脈瘤の1例, ;;;;;;;;;, Sep. 2005, 529回, 31
  • SVGからのretrograde approachでPCIに成功したCTOの一例, ;;;;;;;;;;;, Oct. 2005, 69, Suppl.III, 888
  • 右冠動脈入口部から末梢にかけてのびまん性冠攣縮による完全閉塞により急性心筋梗塞を発症した症例, ;;;;;;;;;;;;, Oct. 2005, 69, Suppl.III, 922
  • Candidaによる感染性心内膜炎(IE)を発症し,内科的・外科的治療により根治し得た心室中隔欠損症(VSD)の一例, ;;;;;;;;;;;;, Apr. 2006, 70, Suppl.II, 1100
  • 循環器領域でClopidogrelに期待されること, ;;;;;;;;;;;;;, Aug. 2005, 55, 3, 298
  • 多彩な感染症を同時期に合併し,全身性クリプトコッカス症で死亡した後天性免疫不全症候群(AIDS)の一剖検例, ;;;;, May 2003, 508回, 24
  • 重粒子線治療を行った局所進行膵臓癌患者におけるFDG-PET/CT(SUVgluc)による治療効果の予測, ;;;;;;;;, Sep. 2022, 59回, S394
  • 観察研究のSDVはどこまで必要か モニタリングを受け入れる医療機関の立場から, ;;;;;;, Jan. 2024, 44回, 3
  • 重粒子線治療を行った局所進行膵臓癌患者におけるFDG-PET/CT(SUVgluc)による治療効果の予測, ;;;;;;;;, Sep. 2022, 59回, S394
  • 観察研究のSDVはどこまで必要か モニタリングを受け入れる医療機関の立場から, ;;;;;;, Jan. 2024, 44回, 3

Books etc

  • Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease" - 1st edition, Joint work, Ohyama Y, Redheuil A, Kachenoura N, Ambale-Venkatesh B, Lima J, Chapter 4. MRI for the assessment of aortic stiffness and pulsatile hemodynamics., Elsevier, 2022, Textbook

Presentations

  • メガホスピタル「前橋・高崎・渋川・深谷コア5治験・臨床研究病院」における特定臨床研究の実施 -コロナ禍における臨床研究ネットワークの効率的な運用-, 大山善昭、住吉尚子、増井和美、齋藤悦子、久保田有香、須賀宏之、金佳虎、小林敦、澤村守夫、柿崎暁、大上美穂、中村哲也, 第42回日本臨床薬理学会学術総会, 09 Dec. 2021, 09 Dec. 2021
  • Physician-induced Demand for acute Cardiovascular Inpatient Care in Japan: An analysis of 3,546,181 admissions from JROAD Database, Ohyama Y, Nakai M, Sumita Y, Iwanaga Y, Nakamura T, Kurabayashi M, Negishi K, American College of Cardiology Scientific Sessions 2022, 2022, 02 Apr. 2022, 04 Apr. 2022
  • Does Physician-induced Demand exist in acute cardiovascular inpatient care in Japan? An analysis of 3,546,181 admissions from JROAD Database., Ohyama Y, Nakai M, Sumita Y, Iwanaga Y, Nakamura T, Kurabayashi M, Negishi K, The 86th Scientific Meeting of the Japanese Circulation Society, 13 Mar. 2022, 11 Mar. 2022, 13 Mar. 2022

Social Contribution

Social Contribution

  • 治験ってなんだろう, 02 Aug. 2021, 22 Aug. 2021 (Target: Schoolchildren, Junior high school students, Guardians, General, Scientific organization)


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.